NCT03431272View on ClinicalTrials.gov

Use of 5.0% Lifitegrast Ophthalmic Solution for the Treatment of Dry Eye Disease in Contact Lens Wearers

PHASE4WithdrawnINTERVENTIONAL

0

Timeline

Start Date

November 1, 2018

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2019

Conditions

Contact Lens Dry Eye

Interventions

DRUG

Lifitegrast

Eye drop

Trial Locations (1)

35294

University of Alabama at Birmingham, Birmingham

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Shire

INDUSTRY

lead

University of Alabama at Birmingham

OTHER